Search

alt
0500

FiltersClear filters

Status
Sex
Age

Pfizer clinical trials

Search Results

We found 6 clinical trials for: Myeloma,Multiple Myeloma, 150 miles

4 trials recruiting
MagnetisMM Clinical Trials
These studies will evaluate the safety and effectiveness of a study medicine, called elranatamab, in people with multiple myeloma.
  • Myeloma
  • Recruiting
View studies
Recruiting
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
  • Myeloma
  • Recruiting
NCT05623020
Sex: All
Age: 18+
Locations: 50
View study
Recruiting
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
  • Myeloma
  • Recruiting
NCT06215118
Sex: All
Age: 18+
Locations: 43
View study
Recruiting
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
  • Myeloma
  • Recruiting
NCT05020236
Sex: All
Age: 18+
Locations: 238
View study
Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
  • Myeloma
  • Recruiting
NCT06152575
Sex: All
Age: 18+
Locations: 277
View study
Recruiting
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
  • Myeloma
  • Recruiting
NCT06057402
Sex: All
Age: 18+
Locations: 29
View study
Mar 31, 2026 - Planned start date (Not yet recruiting)
A Real World Study of Elranatamab in Patients With RR Multiple Myeloma in Taiwan
  • Myeloma
  • Not yet recruiting
NCT07391761
Sex: All
Age: 18+
Locations: 1
View study